Diabetes cell therapies take evasive action

Diabetes cell therapies take evasive action

Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2022-03, Vol.40 (3), p.291-295
1. Verfasser: Dolgin, Elie
Format: Artikel
Sprache:eng
Schlagworte:
Agriculture
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Cell therapy
Diabetes
Diabetes mellitus
Diabetes Mellitus - therapy
Evasive actions
Genetic modification
Humans
Life Sciences
News Feature
Stem cells
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
ISSN:1087-0156
1546-1696
DOI:10.1038/s41587-022-01246-w